Monday, December 04, 2023 1:00:17 AM
I'm no fan of Alabama, but I'd say the odds are pretty good that they'll be the national champion again, all because a review wasn't done after a long completion, where control of the ball was clearly lost on the ground when watched in detail, but they didn't review the play. The resulting touchdown cost Georgia their number 1 rating, and moved them completely out of the playoff picture. My Ram's amazingly were in the playoffs for a few hours until Green Bay knocked off Kansas City, who really should have had a better shot at a tie after an obvious pass interference call wasn't made. Do the refs give home field advantages, perhaps not intentionally, but it generally seems to be the case. In baseball, how many players strike out on balls clearly way out of the electronic device, or oppositely get walks on balls that are clearly in the strike zone. None of the experts picked Green Bay to win, and many self proclaimed experts here are positive that NWBO will lose because they're not doing things the normal way.
I guess I'm saying that you can never be absolutely sure of an outcome, or how the officials will call a play, or the regulators will call the results of a trial. I feel strong about DCVax-L's chances of approval the first time through, but nothing is 100% sure. There is no doubt in my mind that DCVax-L is needed, and at some time will be very big, but I can't say it will happen on a particular day, month, or even year. I've never had a product that I felt certain would be approved and not have it approved, but some were certainly not approved on their first time they were sent to the regulators. I think DCVax-L should be, but nothing is absolutely certain with the regulators any more than an official calling balls and strikes, or penalties in a football game, etc.
Gary
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM